← All peptidesSexual Health
PT-141 (Bremelanotide)
Bremelanotide (Vyleesi)
Melanocortin receptor agonist. FDA-approved for HSDD in women, off-label for men.
Typical dose
1–2 mg
Frequency
As needed, 30-60 min before activity
Half-life
2.7 h
Route
subcutaneous
Typical vial sizes
10 mg
Sample reconstitution
10 mg vial · 2 mL bac water · 1.5 mg dose
- Draw volume
- 0.300 mL
- Insulin units
- 30 units
- Concentration
- 5.00 mg/mL
- Doses per vial
- 6.7
Research notes
May cause flushing, nausea. Start low.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.